scroll down
Global API CDMO Company
Walking with partners,
Creating value
Creating value
Technology-driven gene therapy CDMO
from oligonucleotide to xRNA
View our Science & TechnologyGlobal API CDMO Company
Walking with Partners, Creating Value
Walking with Partners, Creating Value
30+years
Track record
40+
Global CDMO Project
6.4mole
Oligo CDMO Capacity ('22)
1.0kg / year
mRNA CDMO Capacity
IR Library
- [Update] IR Material based on 3Q Quarterly ReportNov 19, 2024
- [IR Material] Macquarie Securities Korea NDR (Hong Kong / Singapore)Nov 1, 2024
- [Earning Call] 2024 3rd Quarter Earning Call Presentation MaterialNov 1, 2024
- [IR Material] Korea Investment Week 2024Sep 6, 2024
- [IR Materials] mRNA Platform TechnologyMar 14, 2023